Rocket Pharmaceuticals, Inc. ( RCKT) - Key Metrics
RCKT Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | ? | ? | ? | ? |
| 2025Q3 | ? | -$0.45 | -$0.45 | -$0.45 |
| 2025Q2 | ? | -$0.62 | -$0.44 | -$0.44 |
| 2025Q1 | ? | -$0.56 | -$0.51 | -$0.51 |
RCKT Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | ? |
| 2025Q3 | ? | -1.81 |
| 2025Q2 | ? | -0.99 |
| 2025Q1 | ? | -2.99 |
RCKT
Price: $2.80
52 week price:
Earnings Per Share: -1.90 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 607900
Market Capitalization: 300.3 million